Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5)

Citrate is a key regulatory metabolic intermediate as it facilitates the integration of the glycolysis and lipid synthesis pathways. Inhibition of hepatic extracellular citrate uptake, by blocking the sodium-coupled citrate transporter (NaCT or SLC13A5), has been suggested as a potential therapeutic...

Full description

Saved in:
Bibliographic Details
Published in:Sci Rep
Main Authors: Huard, Kim, Brown, Janice, Jones, Jessica C., Cabral, Shawn, Futatsugi, Kentaro, Gorgoglione, Matthew, Lanba, Adhiraj, Vera, Nicholas B., Zhu, Yimin, Yan, Qingyun, Zhou, Yingjiang, Vernochet, Cecile, Riccardi, Keith, Wolford, Angela, Pirman, David, Niosi, Mark, Aspnes, Gary, Herr, Michael, Genung, Nathan E., Magee, Thomas V., Uccello, Daniel P., Loria, Paula, Di, Li, Gosset, James R., Hepworth, David, Rolph, Timothy, Pfefferkorn, Jeffrey A., Erion, Derek M.
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2015
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4664966/
https://ncbi.nlm.nih.gov/pubmed/26620127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep17391
Tags: Add Tag
No Tags, Be the first to tag this record!

因特網

https://ncbi.nlm.nih.gov/pmc/articles/PMC4664966/
https://ncbi.nlm.nih.gov/pubmed/26620127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep17391

Similar Items